Agency Information Collection Activities: Proposed Collection; Comment Request, 41991-41993 [2019-17663]
Download as PDF
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 159 / Friday, August 16, 2019 / Notices
E–69, Atlanta, GA 30329, phone: (404)
498–6778, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Meeting Accessibility: This spacelimited meeting is open to the public.
All meeting attendees must register. To
ensure completion of required security
procedures and access to the CDC’s
Global Communications Center, U.S.
citizens intending to attend in person
must register by October 11, 2019, and
non-U.S. citizens intending to attend in
person must register by September 11,
2019. Failure to register by the dates
identified could result in the inability to
attend the CPSTF meeting in person.
Those unable to attend the meeting in
person are able to do so via Webcast.
CDC will send the Webcast URL to
registrants upon receipt of their
registration. All meeting attendees must
register by October 11, 2019 to receive
the webcast information. CDC will email
webcast information from the CPSTF@
cdc.gov mailbox.
To register for the meeting, whether to
attend in person or via webcast,
individuals should send an email to
CPSTF@cdc.gov and include the
following information: name, title,
organization name, organization
address, phone, email, and whether
attending in person or via webcast.
Public Comment: A public comment
period, limited to three minutes per
person, will follow the CPSTF’s
discussion of each systematic review.
Individuals wishing to make public
comments must indicate their desire to
do so with their registration by
providing their name, organizational
affiliation, and the topic to be addressed
(if known). Public comments will
become part of the meeting summary.
Public comment is not possible via
Webcast.
Background on the CPSTF: The
CPSTF is an independent, nonfederal
panel whose members are appointed by
the CDC Director. CPSTF members
represent a broad range of research,
practice, and policy expertise in
prevention, wellness, health promotion,
and public health. The CPSTF was
convened in 1996 by the Department of
Health and Human Services (HHS) to
identify community preventive
programs, services, and policies that
increase healthy longevity, save lives
and dollars, and improve Americans’
quality of life. CDC is mandated to
provide ongoing administrative,
research, and technical support for the
operations of the CPSTF. During its
meetings, the CPSTF considers the
findings of systematic reviews on
existing research and practice-based
evidence and issues recommendations.
VerDate Sep<11>2014
16:10 Aug 15, 2019
Jkt 247001
CPSTF recommendations are not
mandates for compliance or spending.
Instead, they provide information about
evidence-based options that decision
makers and stakeholders can consider
when they are determining what best
meets the specific needs, preferences,
available resources, and constraints of
their jurisdictions and constituents. The
CPSTF’s recommendations, along with
the systematic reviews of the evidence
on which they are based, are compiled
in the The Community Guide.
Matters proposed for discussion:
Cancer Prevention and Control; Obesity
Prevention and Control; Pregnancy
Health; and Tobacco Cessation.
The agenda is subject to change
without notice.
Roybal Campus Security Guidelines:
The Edward R. Roybal Campus is the
headquarters of the CDC and is located
at 1600 Clifton Road NE, Atlanta,
Georgia. The meeting is being held in a
Federal government building; therefore,
Federal security measures are
applicable.
All meeting attendees must register by
the dates outlined under Meeting
Accessability. In planning your arrival
time, please take into account the need
to park and clear security. All visitors
must enter the Edward R. Roybal
Campus through the front entrance on
Clifton Road. Vehicles may be searched,
and the guard force will then direct
visitors to the designated parking area.
Upon arrival at the facility, visitors must
present government-issued photo
identification (e.g., a valid federal
identification badge, state driver’s
license, state non-driver’s identification
card, or passport). Non-United States
citizens must complete the required
security paperwork prior to the meeting
date and must present a valid passport,
visa, Permanent Resident Card, or other
type of work authorization document
upon arrival at the facility. Instructions
for completing the required security
paperwork will be provided after
registration. All persons entering the
building must pass through a metal
detector. CDC Security personnel will
issue a visitor’s ID badge at the entrance
to Building 19. Visitors may receive an
escort to the meeting room. All items
brought to HHS/CDC are subject to
inspection.
Dated: August 13, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2019–17658 Filed 8–15–19; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
41991
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10137 and CMS–
10191]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
October 15, 2019.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
SUMMARY:
E:\FR\FM\16AUN1.SGM
16AUN1
41992
Federal Register / Vol. 84, No. 159 / Friday, August 16, 2019 / Notices
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10137 Title Solicitation for
Applications for Medicare Prescription
Drug Plan 2021 Contracts
CMS–10191 Medicare Parts C and D
Program Audit Protocols and Data
Requests
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
khammond on DSKBBV9HB2PROD with NOTICES
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Solicitation for
Applications for Medicare Prescription
Drug Plan 2021 Contracts; Use: Coverage
for the prescription drug benefit is
provided through contracted
VerDate Sep<11>2014
16:10 Aug 15, 2019
Jkt 247001
prescription drug plans (PDPs) or
through Medicare Advantage (MA)
plans that offer integrated prescription
drug and health care coverage (MA–PD
plans). Cost Plans that are regulated
under Section 1876 of the Social
Security Act, and Employer Group
Waiver Plans (EGWP) may also provide
a Part D benefit. Organizations wishing
to provide services under the
Prescription Drug Benefit Program must
complete an application, negotiate rates,
and receive final approval from CMS.
Existing Part D Sponsors may also
expand their contracted service area by
completing the Service Area Expansion
(SAE) application.
Collection of this information is
mandated in Part D of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) in
Subpart 3. The application requirements
are codified in Subpart K of 42 CFR 423
entitled ‘‘Application Procedures and
Contracts with PDP Sponsors.’’
The information will be collected
under the solicitation of proposals from
PDP, MA–PD, Cost Plan, Program of All
Inclusive Care for the Elderly (PACE),
and EGWP applicants. The collected
information will be used by CMS to: (1)
Ensure that applicants meet CMS
requirements for offering Part D plans
(including network adequacy,
contracting requirements, and
compliance program requirements, as
described in the application), (2)
support the determination of contract
awards. Form Number: CMS–10137
(OMB control number: 0938–0936);
Frequency: Yearly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 243; Total
Annual Responses: 290; Total Annual
Hours: 1,384.79. (For policy questions
regarding this collection contact
Arianne Spaccarelli at 410–786–5715.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Parts
C and D Program Audit Protocols and
Data Requests; Use: Under the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 and
implementing regulations at 42 CFR
parts 422 and 423, Medicare Part D plan
sponsors and Medicare Advantage
organizations are required to comply
with all Medicare Parts C and D
program requirements. CMS’ annual
audit plan ensures that we evaluate
sponsoring organizations’ compliance
with these requirements. CMS program
audits focus on high-risk areas that have
the greatest potential for beneficiary
harm. As such, CMS has developed
several audit protocols that are included
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
within the program area data request
documents and that are posted to the
CMS website each year for use by
sponsoring organizations to prepare for
their audit. As part of a robust audit
process, CMS also requires sponsoring
organizations who have been audited
and found to have deficiencies to
undergo a validation audit to ensure
correction. The validation audit utilizes
the same audit protocols, but only tests
the elements where deficiencies were
found, as opposed to re-administering
the entire audit.
Currently CMS utilizes the following
5 protocols to audit sponsoring
organization performance: Part D
Formulary and Benefit Administration
(FA); Coverage Determinations,
Appeals, and Grievances (CDAG);
Organization Determinations, Appeals,
and Grievances (ODAG); Special Needs
Model of Care (SNP–MOC) (only
administered on organizations who
operate SNPs); and, Compliance
Program Effectiveness (CPE). The data
collected is detailed in each of these
protocols and the exact fields are
located in the record layouts, at the end
of each protocol. In addition, this
collection request includes a pre-audit
issue summary, three CPE
questionnaires, one CPE organizational
structure presentation template, one FA
impact analysis template, two CDAG
impact analysis templates, four OAG
impact analysis templates, and three
SNP–MOC impact analysis templates.
The information gathered during this
audit will be used by the Medicare Parts
C and D Oversight and Enforcement
Group (MOEG) within the Center for
Medicare (CM) and CMS Regional
Offices to assess sponsoring
organizations’ compliance with
Medicare program requirements. If
outliers or other data anomalies are
detected, Regional Offices will work in
collaboration with (MOEG) and other
divisions within CMS for follow-up and
resolution. Additionally, MA and Part D
organizations will receive the audit
results and will be required to
implement corrective action to correct
any identified deficiencies. Form
Number: CMS–10191 (OMB control
number: 0938–1000); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
201; Total Annual Responses: 207; Total
Annual Hours: 17,525. (For policy
questions regarding this collection
contact Brenda Hudson at 303–844–
7056.)
E:\FR\FM\16AUN1.SGM
16AUN1
Federal Register / Vol. 84, No. 159 / Friday, August 16, 2019 / Notices
Dated: August 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
[FR Doc. 2019–17663 Filed 8–15–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKBBV9HB2PROD with NOTICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
240: Innovative Research in Cancer
Nanotechnology.
Date: September 17, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Chevy Chase
Pavillion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17606 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:10 Aug 15, 2019
Jkt 247001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel Rare Disease Applications.
Date: September 10, 2019.
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, 6701 Democracy
Blvd., Rm 1078, Bethesda, MD 20892, 301–
594–7319, khanr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17609 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RM19–001:
SPARC/HEAL Mapping of Pain-Related
Visceral Organ Neural Circuitry.
Date: August 23, 2019.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–17608 Filed 8–15–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke, Interagency Pain
Research Coordinating Committee Call
for Committee Membership
Nominations
AGENCY:
National Institutes of Health,
HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
National Institutes of Health
SUMMARY:
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
41993
Notice.
The Department of Health and
Human Services (HHS) (Department)
has created the Interagency Pain
Research Coordinating Committee
(IPRCC) and is seeking nominations for
this committee.
DATES: Nominations are due by COB
September 23, 2019.
ADDRESSES: Nominations must be
submitted through the webform on the
IPRCC website: https://iprcc.nih.gov/
About/Membership-AgencyRepresentation/Nomination-Form.
FOR FURTHER INFORMATION CONTACT:
Linda Porter, porterl@ninds.nih.gov or
301–451–4460.
E:\FR\FM\16AUN1.SGM
16AUN1
Agencies
[Federal Register Volume 84, Number 159 (Friday, August 16, 2019)]
[Notices]
[Pages 41991-41993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17663]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10137 and CMS-10191]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by October 15, 2019.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
[[Page 41992]]
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to [email protected].
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10137 Title Solicitation for Applications for Medicare Prescription
Drug Plan 2021 Contracts
CMS-10191 Medicare Parts C and D Program Audit Protocols and Data
Requests
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Solicitation for
Applications for Medicare Prescription Drug Plan 2021 Contracts; Use:
Coverage for the prescription drug benefit is provided through
contracted prescription drug plans (PDPs) or through Medicare Advantage
(MA) plans that offer integrated prescription drug and health care
coverage (MA-PD plans). Cost Plans that are regulated under Section
1876 of the Social Security Act, and Employer Group Waiver Plans (EGWP)
may also provide a Part D benefit. Organizations wishing to provide
services under the Prescription Drug Benefit Program must complete an
application, negotiate rates, and receive final approval from CMS.
Existing Part D Sponsors may also expand their contracted service area
by completing the Service Area Expansion (SAE) application.
Collection of this information is mandated in Part D of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
(MMA) in Subpart 3. The application requirements are codified in
Subpart K of 42 CFR 423 entitled ``Application Procedures and Contracts
with PDP Sponsors.''
The information will be collected under the solicitation of
proposals from PDP, MA-PD, Cost Plan, Program of All Inclusive Care for
the Elderly (PACE), and EGWP applicants. The collected information will
be used by CMS to: (1) Ensure that applicants meet CMS requirements for
offering Part D plans (including network adequacy, contracting
requirements, and compliance program requirements, as described in the
application), (2) support the determination of contract awards. Form
Number: CMS-10137 (OMB control number: 0938-0936); Frequency: Yearly;
Affected Public: State, Local, or Tribal Governments; Number of
Respondents: 243; Total Annual Responses: 290; Total Annual Hours:
1,384.79. (For policy questions regarding this collection contact
Arianne Spaccarelli at 410-786-5715.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare Parts C
and D Program Audit Protocols and Data Requests; Use: Under the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
and implementing regulations at 42 CFR parts 422 and 423, Medicare Part
D plan sponsors and Medicare Advantage organizations are required to
comply with all Medicare Parts C and D program requirements. CMS'
annual audit plan ensures that we evaluate sponsoring organizations'
compliance with these requirements. CMS program audits focus on high-
risk areas that have the greatest potential for beneficiary harm. As
such, CMS has developed several audit protocols that are included
within the program area data request documents and that are posted to
the CMS website each year for use by sponsoring organizations to
prepare for their audit. As part of a robust audit process, CMS also
requires sponsoring organizations who have been audited and found to
have deficiencies to undergo a validation audit to ensure correction.
The validation audit utilizes the same audit protocols, but only tests
the elements where deficiencies were found, as opposed to re-
administering the entire audit.
Currently CMS utilizes the following 5 protocols to audit
sponsoring organization performance: Part D Formulary and Benefit
Administration (FA); Coverage Determinations, Appeals, and Grievances
(CDAG); Organization Determinations, Appeals, and Grievances (ODAG);
Special Needs Model of Care (SNP-MOC) (only administered on
organizations who operate SNPs); and, Compliance Program Effectiveness
(CPE). The data collected is detailed in each of these protocols and
the exact fields are located in the record layouts, at the end of each
protocol. In addition, this collection request includes a pre-audit
issue summary, three CPE questionnaires, one CPE organizational
structure presentation template, one FA impact analysis template, two
CDAG impact analysis templates, four OAG impact analysis templates, and
three SNP-MOC impact analysis templates.
The information gathered during this audit will be used by the
Medicare Parts C and D Oversight and Enforcement Group (MOEG) within
the Center for Medicare (CM) and CMS Regional Offices to assess
sponsoring organizations' compliance with Medicare program
requirements. If outliers or other data anomalies are detected,
Regional Offices will work in collaboration with (MOEG) and other
divisions within CMS for follow-up and resolution. Additionally, MA and
Part D organizations will receive the audit results and will be
required to implement corrective action to correct any identified
deficiencies. Form Number: CMS-10191 (OMB control number: 0938-1000);
Frequency: Yearly; Affected Public: State, Local, or Tribal
Governments; Number of Respondents: 201; Total Annual Responses: 207;
Total Annual Hours: 17,525. (For policy questions regarding this
collection contact Brenda Hudson at 303-844-7056.)
[[Page 41993]]
Dated: August 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2019-17663 Filed 8-15-19; 8:45 am]
BILLING CODE 4120-01-P